Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.

Mulliez, S M N; De Keyser, F; Verbist, C; Vantilborgh, A; Wijns, W; Beukinga, I; Devreese, K M J

Mulliez, S M N; De Keyser, F; Verbist, C; Vantilborgh, A; Wijns, W; Beukinga, I; Devreese, K M J.

Afiliación

Mulliez SM; Coagulation Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium.
De Keyser F; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Verbist C; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
Vantilborgh A; Department of Hematology, Ghent University Hospital, Ghent, Belgium.
Wijns W; Department of Hematobiology, Erasme Hospital, Brussels, Belgium.
Beukinga I; Department of Hematobiology, Erasme Hospital, Brussels, Belgium.
Devreese KM; Coagulation Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium katrien.devreese@uzgent.be.

Lupus ; 24(7): 736-45, 2015 Jun.

Article en En | MEDLINE | ID: mdl-25391540

Asunto(s)

Síndrome Antifosfolípido/sangre; Hipoprotrombinemias/sangre; Inhibidor de Coagulación del Lupus/sangre; Lupus Eritematoso Sistémico/sangre; Adulto; Anticuerpos Antifosfolípidos/sangre; Preescolar; Femenino; Humanos; Masculino

Palabras clave

Lupus anticoagulant; acquired hypoprothrombinemia; antiprothrombin antibodies; bleeding; hypoprothrombinemia; prothrombin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidor de Coagulación del Lupus / Síndrome Antifosfolípido / Hipoprotrombinemias / Lupus Eritematoso Sistémico Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google